Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Senke Pharmaceutical is a Chinese pharmaceutical company based in Chengdu, Sichuan, specializing in the development and production of chemical drugs and active pharmaceutical ingredients. Founded in 2003, the company has established a strong presence in the domestic market with a focus on hepatology, cardiovascular, and gastrointestinal therapeutic areas. Its flagship products include Ornithine Aspartate for liver diseases and various treatments for chronic conditions like angina and gastric ulcers. The company operates state-of-the-art manufacturing facilities that adhere to national GMP standards, ensuring high-quality production of injections, tablets, and granules. Chengdu Senke continues to expand its portfolio through a combination of generic drug optimization and targeted research into specialized chemical medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Senke Pharmaceutical.